Be the first person to write a business review for Arsenal Capital Partners, Inc.

Ascendant Solutions, Inc. was founded in 1997. Ascendant Solutions, Inc. ("Ascendant") is a value oriented investment firm focused on making equity investments in underperforming or distressed U.S. lower middle-market businesses. Ascendant is primarily interested in investing or acquiring, in manufacturing, distribution, service, healthcare, finance and retail industries with $20 to $150 million in annual revenues that require access to capital or capital restructuring, and strategic support to improve operational performance. Ascendant currently has approximately $40 million in net operating loss carryforwards, which can be used to shelter future income, thus enhancing free cash flow or debt service capabilities.

Asset Value Investors was established in 1985. Asset Value Investors (formerly Ivory & Sime Asset Management) wants to increase the value of investors' assets. The UK firm primarily manages a handful of funds, which invest in a variety of assets. British Empire Securities and General Trust plc is a closed-end investment trust, while The European Asset Value Fund allows investors to participate in listed European property. Asset Value Investors company also manages the CF Asset Value Global Investors Fund, which focuses on foreign undervalued stocks, and AVI Value Fund, a US endowment portfolio. Funds under management total more than $3.4 billion.

Astaire Group Plc is a United Kingdom-based company. Its principal activities include investment banking, private client stock broking and wealth management. It has two divisions: Investment banking, and Private client and wealth management. Investment banking is engaged in London-based corporate finance, corporate broking and United Kingdom and international equities business. Private client and wealth management is engaged in the London and South West-focused branch network of executives providing personalized stock broking and wealth management services to individuals, charities and pension funds. During the year ended December 31, 2009, the Company sold its Australian business, Inteq Limited. On July 22, 2009, it has acquired Ruegg & Co Limited and on October 23, 2009 it has acquired Dowgate Capital Plc.

Astellas Venture Management invests in seed-stage and emerging biotech companies, including drug discovery and development companies. The firm manages four venture funds, and its portfolio includes more than 20 companies. Astellas Venture Management is the venture capital arm of Astellas Pharma, formed from the 2005 merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. Astellas Venture Management provides its portfolio companies not only with cash, but also access to the scientific expertise, production facilities, and marketing clout of its parent firm.

Astellas Venture Management invests in seed-stage and emerging biotech companies, including drug discovery and development companies. The firm manages four venture funds, and its portfolio includes more than 20 companies. Astellas Venture Management is the venture capital arm of Astellas Pharma, formed from the 2005 merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. Astellas Venture Management provides its portfolio companies not only with cash, but also access to the scientific expertise, production facilities, and marketing clout of its parent firm.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.